Sino Biopharmaceutical Stock
Sino Biopharmaceutical Stock price
Key metrics
Is Sino Biopharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 7,029 stocks worldwide.
Sino Biopharmaceutical Stock Analysis
Analyst Opinions
27 Analysts have issued a Sino Biopharmaceutical forecast:
Analyst Opinions
27 Analysts have issued a Sino Biopharmaceutical forecast:
Financial data from Sino Biopharmaceutical
| Dec '24 |
+/-
%
|
||
| Revenue | 31,418 31,418 |
15%
15%
|
|
| Gross Profit | 25,610 25,610 |
13%
13%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 5,943 5,943 |
6%
6%
|
| Net Profit | 3,809 3,809 |
50%
50%
|
|
In millions HKD.
Don't miss a Thing! We will send you all news about Sino Biopharmaceutical directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.
| Head office | Cayman Islands |
| CEO | S Tse |
| Employees | 24,379 |
| Founded | 2000 |
| Website | www.sinobiopharm.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
